Next Article in Journal

Prevalence of Homologous Recombination Deficiency in First-Line PARP Inhibitor Maintenance Clinical Trials and Further Implication of Personalized Treatment in Ovarian Cancer

Next Article in Special Issue

Cetuximab for Immunotherapy-Refractory/Ineligible Cutaneous Squamous Cell Carcinoma

Previous Article in Journal

Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers

Previous Article in Special Issue

The Prognostic Value and Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test in Cutaneous Squamous Cell Carcinoma: Systematic Review and Meta-Analysis

You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.

Search for Articles:

Title / Keyword

Author / Affiliation / Email

Journal

Article Type

Advanced Search

Section

Special Issue

Volume

Issue

Number

Page

Logical OperatorOperator

Search Text

Search Type

Submit to this Journal Review for this Journal Propose a Special Issue

Article Menu

Share Help Cite Discuss in SciProfiles

Open AccessReview

Article Versions Notes

Cancers 2023, 15(12), 3094; https://doi.org/10.3390/cancers15123094

Action	Date	Notes	Link
article xml file uploaded	7 June 2023 12:21 CEST	Original file	-
article xml uploaded.	7 June 2023 12:21 CEST	Update	https://www.mdpi.com/2072-6694/15/12/3094/xml
article pdf uploaded.	7 June 2023 12:22 CEST	Version of Record	https://www.mdpi.com/2072-6694/15/12/3094/pdf
article html file updated	7 June 2023 12:23 CEST	Original file	-
article html file updated	20 June 2023 21:08 CEST	Update	https://www.mdpi.com/2072-6694/15/12/3094/html

Back to TopTop